Mynd Lifesciencs Stock Net Income
| MYNDF Stock | USD 0.01 0.00 0.00% |
As of the 9th of February, MYND Lifesciencs secures the mean deviation of 1.86, and Risk Adjusted Performance of (0). Concerning fundamental indicators, the technical analysis model lets you check available technical drivers of MYND Lifesciencs, as well as the relationship between them. Please verify MYND Lifesciencs risk adjusted performance, standard deviation, as well as the relationship between the Standard Deviation and maximum drawdown to decide if MYND Lifesciencs is priced favorably, providing market reflects its recent price of 0.0081 per share. As MYND Lifesciencs appears to be a penny stock we also strongly suggest to check its information ratio numbers.
MYND Lifesciencs' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing MYND Lifesciencs' valuation are provided below:MYND Lifesciencs does not currently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. MYND |
MYND Lifesciencs 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MYND Lifesciencs' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MYND Lifesciencs.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in MYND Lifesciencs on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding MYND Lifesciencs or generate 0.0% return on investment in MYND Lifesciencs over 90 days. MYND Lifesciencs is related to or competes with Rocket Pharmaceuticals, Aura Biosciences, Annexon, Solid Biosciences, Larimar Therapeutics, Altimmune, and Autolus Therapeutics. MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based o... More
MYND Lifesciencs Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MYND Lifesciencs' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MYND Lifesciencs upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 113.6 |
MYND Lifesciencs Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MYND Lifesciencs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MYND Lifesciencs' standard deviation. In reality, there are many statistical measures that can use MYND Lifesciencs historical prices to predict the future MYND Lifesciencs' volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | 0.0577 | |||
| Total Risk Alpha | (1.14) | |||
| Treynor Ratio | 0.0576 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MYND Lifesciencs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
MYND Lifesciencs February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | 0.0676 | |||
| Mean Deviation | 1.86 | |||
| Coefficient Of Variation | (7,128) | |||
| Standard Deviation | 10.0 | |||
| Variance | 99.91 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | 0.0577 | |||
| Total Risk Alpha | (1.14) | |||
| Treynor Ratio | 0.0576 | |||
| Maximum Drawdown | 113.6 | |||
| Skewness | (1.38) | |||
| Kurtosis | 33.36 |
MYND Lifesciencs Backtested Returns
MYND Lifesciencs has Sharpe Ratio of -0.0142, which conveys that the firm had a -0.0142 % return per unit of volatility over the last 3 months. MYND Lifesciencs exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify MYND Lifesciencs' mean deviation of 1.86, and Risk Adjusted Performance of (0) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -2.61, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning MYND Lifesciencs are expected to decrease by larger amounts. On the other hand, during market turmoil, MYND Lifesciencs is expected to outperform it. At this point, MYND Lifesciencs has a negative expected return of -0.14%. Please make sure to verify MYND Lifesciencs' information ratio and kurtosis , to decide if MYND Lifesciencs performance from the past will be repeated at some future point.
Auto-correlation | 0.00 |
No correlation between past and present
MYND Lifesciencs has no correlation between past and present. Overlapping area represents the amount of predictability between MYND Lifesciencs time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MYND Lifesciencs price movement. The serial correlation of 0.0 indicates that just 0.0% of current MYND Lifesciencs price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, MYND Lifesciencs reported net income of (4.37 Million). This is 101.28% lower than that of the Healthcare sector and 106.23% lower than that of the Biotechnology industry. The net income for all United States stocks is 100.76% higher than that of the company.
MYND Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MYND Lifesciencs' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of MYND Lifesciencs could also be used in its relative valuation, which is a method of valuing MYND Lifesciencs by comparing valuation metrics of similar companies.MYND Lifesciencs is currently under evaluation in net income category among its peers.
MYND Fundamentals
| Return On Asset | -2.01 | |||
| Operating Margin | 88.18 % | |||
| Current Valuation | 3.87 M | |||
| Shares Outstanding | 46.82 M | |||
| Shares Owned By Insiders | 31.12 % | |||
| EBITDA | (4.31 M) | |||
| Net Income | (4.37 M) | |||
| Cash And Equivalents | 12.52 K | |||
| Total Debt | 2 M | |||
| Debt To Equity | 0.90 % | |||
| Current Ratio | 0.42 X | |||
| Book Value Per Share | (0.06) X | |||
| Cash Flow From Operations | (2.98 M) | |||
| Earnings Per Share | (0.08) X | |||
| Market Capitalization | 2.1 M | |||
| Total Asset | 2.67 M | |||
| Z Score | -2.7 | |||
| Net Asset | 2.67 M |
About MYND Lifesciencs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MYND Lifesciencs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MYND Lifesciencs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MYND Lifesciencs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in MYND Pink Sheet
MYND Lifesciencs financial ratios help investors to determine whether MYND Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MYND with respect to the benefits of owning MYND Lifesciencs security.